Adaptation to glucose restriction and β-hydroxybutyrate supplementation is associated with metabolic flexibility in lung cancer cells

Metabolic reprogramming in tumor cells involves alterations in enzymatic machinery and metabolic profile reflect adaptive changes in malignant phenotypes. This study assessed the metabolic adaptability of A549 lung cancer cells under glucose restriction and β-hydroxybutyrate supplementation. Cells were cultured in media with varying glucose concentrations, with or without β-hydroxybutyrate. Targeted metabolomic analysis of conditioned media quantified 20 amino acids and 30 acylcarnitines using liquid chromatography–tandem mass spectrometry (LC-MS/MS). Multivariate statistical analysis revealed distinct metabolic signatures and clear clustering of experimental groups based on extracellular metabolite profiles. The glucose-restricted, β-hydroxybutyrate–supplemented group exhibited a uniquely distinct pattern with specific alterations in extracellular amino acids (e.g., methionine, citrulline) and carnitine derivatives. Treated groups showed decreased tryptophan and increased arginine levels, suggesting altered tryptophan utilization coupled with coordinated shifts in arginine metabolism during metabolic stress. Notably, short-chain acylcarnitine species were elevated across all comparisons (Glucose-restricted- β-hydroxybutyrate-enriched group vs. control, Glucose-restricted group, and β-hydroxybutyrate-enriched group). These findings underscore the profound impact of substrate availability on cancer cell metabolism, with glucose limitation driving changes in amino acid pools consistent with heightened utilization. Extracellular amino acid and acylcarnitine profiles capture metabolite and pathway shifts linked to altered nutrient conditions; however, functional studies are needed to establish their biological relevance. Importantly, all reported changes reflect concentrations in the culture medium, indicating altered cellular uptake, secretion, or utilization rather than direct measurements of intracellular metabolite pools.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-04-16
DOI
https://doi.org/10.1038/s41598-026-48209-8
Primary Topic
Metabolism, Diabetes, and Cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adaptation to glucose restriction and β-hydroxybutyrate supplementation is associated with metabolic flexibility in lung cancer cells

Masoumeh Tavakoli‐Yaraki, Vahid Salimi, Farzad Izak Shirian, Mohammad Amin Vaezi et al.
Scientific Reports
Metabolism, Diabetes, and Cancer
article

Adaptation to glucose restriction and β-hydroxybutyrate supplementation is associated with metabolic flexibility in lung cancer cells

Masoumeh Tavakoli‐Yaraki, Vahid Salimi, Farzad Izak Shirian, Mohammad Amin Vaezi, Aisa Bahar, Ali Karami, Nahid Safari-Alighiarloo, Ali Mohebbi, Seyyed Mohammad Tabatabaei
article en

Abstract

Metabolic reprogramming in tumor cells involves alterations in enzymatic machinery and metabolic profile reflect adaptive changes in malignant phenotypes. This study assessed the metabolic adaptability of A549 lung cancer cells under glucose restriction and β-hydroxybutyrate supplementation. Cells were cultured in media with varying glucose concentrations, with or without β-hydroxybutyrate. Targeted metabolomic analysis of conditioned media quantified 20 amino acids and 30 acylcarnitines using liquid chromatography–tandem mass spectrometry (LC-MS/MS). Multivariate statistical analysis revealed distinct metabolic signatures and clear clustering of experimental groups based on extracellular metabolite profiles. The glucose-restricted, β-hydroxybutyrate–supplemented group exhibited a uniquely distinct pattern with specific alterations in extracellular amino acids (e.g., methionine, citrulline) and carnitine derivatives. Treated groups showed decreased tryptophan and increased arginine levels, suggesting altered tryptophan utilization coupled with coordinated shifts in arginine metabolism during metabolic stress. Notably, short-chain acylcarnitine species were elevated across all comparisons (Glucose-restricted- β-hydroxybutyrate-enriched group vs. control, Glucose-restricted group, and β-hydroxybutyrate-enriched group). These findings underscore the profound impact of substrate availability on cancer cell metabolism, with glucose limitation driving changes in amino acid pools consistent with heightened utilization. Extracellular amino acid and acylcarnitine profiles capture metabolite and pathway shifts linked to altered nutrient conditions; however, functional studies are needed to establish their biological relevance. Importantly, all reported changes reflect concentrations in the culture medium, indicating altered cellular uptake, secretion, or utilization rather than direct measurements of intracellular metabolite pools.

Scientific Reports
Iran University of Medical Sciences (IR), Mashhad University of Medical Sciences (IR), Children's Medical Center (IR), Tehran University of Medical Sciences (IR)
Iran University of Medical Sciences
Zero hunger
Openalex Percentile: Top 12%
Metabolism, Diabetes, and Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.